| Read Time: 2 minutes

July 5, 2020 – Two more Zantac cancer lawsuits were consolidated into the U.S. District Court of Florida, where the Zantac litigation is pending. The two plaintiffs, one from Pennsylvania and the other from Florida, were both women who claimed that regular use of Zantac lead them (or their decedent) to develop cancer.

The Pennsylvania-based plaintiff filed a claim on behalf of a deceased family member’s estate. The decedent had been diagnosed with pancreatic cancer in 2018, succumbing to the illness on August 31, 2019. According to her complaint, the decedent used Zantac regularly and followed the directions regarding drug usage. The plaintiff’s complaint stated that the decedent would have not used Zantac if he had been aware of the cancer risks associated with Zantac.

The Florida-based plaintiff’s complaint stated that she had begun taking over-the-counter Zantac regularly more than 20 years ago, using both 75 mg and 150 mg does, initially beginning to use the drug to reduce her stomach acid after undergoing an endoscopy. Similar to the Pennsylvania plaintiff’s claim, the Florida plaintiff stated that she used the drug as directed on the label. She began with 75 mg doses but transitioned to 150 mg doses after the higher dose became available in the US market. She also noted that she would have not used Zantac if she had been aware of the cancer risks associated with the drug.

The Florida plaintiff was diagnosed with stage IIC colon cancer in April 2018. She subsequently underwent invasive surgery to have a large part of her colon removed. She has since received various cancer treatments, including chemotherapy treatment.

Both pancreatic cancer and colon cancer have been linked to Zantac use. Both plaintiffs sought compensatory damages as well as punitive damages against the manufacturer.

Reference: Luhana, Roopal. “Plaintiffs File New Zantac Lawsuits, Claim Drug Caused Colon, Pancreatic Cancer.” New York Injury Law News, The Legal Examiner, 5 July 2020, www.newyork.legalexaminer.com/health/plaintiffs-file-new-zantac-lawsuits-claim-drug-caused-colon-pancreatic-cancer/

Author Photo

Gayle Gerling Pettinga

Born and raised in Evansville, Gayle is a respected, experienced lawyer and a valued community leader. She graduated near the top of her class at Indiana University’s prestigious Maurer School of Law. She’s practiced law with one of the largest firms in Indianapolis as well as one of the largest pharmaceutical companies in the world. And that means she knows how big law firms and big companies think and how they operate – and she will put that knowledge to work for you.

Gayle has received numerous awards and honors including Martindale-Hubbell — Peer Review Rated: AV®, American Institute of Personal Injury Attorneys 10 Best Attorneys in Indiana for Exceptional and Outstanding Client Service, and YWCA Evansville 100 Years, 100 Women Honoree, 2011.

Rate this Post

1 Star2 Stars3 Stars4 Stars5 Stars